Point72 Asia (Singapore) Pte. Ltd. Absci Corp Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $480 Billion
- Q2 2024
Shares
2 transactions
Others Institutions Holding ABSI
# of Institutions
115Shares Held
55.3MCall Options Held
190KPut Options Held
114K-
Redmile Group, LLC San Francisco, CA8.25MShares$31.5 Million1.66% of portfolio
-
Fred Alger Management, LLC New York, NY7.26MShares$27.7 Million0.11% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl5.5MShares$21 Million0.15% of portfolio
-
Black Rock Inc. New York, NY5.34MShares$20.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.28MShares$16.4 Million0.0% of portfolio
About Absci Corp
- Ticker ABSI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 92,843,504
- Market Cap $355M
- Description
- Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....